Cita APA

Harada, E., Serada, S., Fujimoto, M., Takahashi, Y., Takahashi, T., Hara, H., . . . Naka, T. (2017). Glypican-1 targeted antibody-based therapy induces preclinical antitumor activity against esophageal squamous cell carcinoma. Oncotarget.

Citación estilo Chicago

Harada, Emi, et al. "Glypican-1 Targeted Antibody-based Therapy Induces Preclinical Antitumor Activity against Esophageal Squamous Cell Carcinoma." Oncotarget 2017.

Cita MLA

Harada, Emi, et al. "Glypican-1 Targeted Antibody-based Therapy Induces Preclinical Antitumor Activity against Esophageal Squamous Cell Carcinoma." Oncotarget 2017.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.